Back

Evaluating the reversibility potential of atrial cardiomyopathy on a clinical and cellular level

26 August 2022 (08:00 - 19:30)
Organised by:
Congress Presentation Part of: Insights in the pathophysiology of atrial fibrillation Pathophysiology and Mechanisms ESC Professional Premium Access ESC Congress 2022

About the speaker

Photo
Doctor Felix Wiedmann

University Hospital Heidelberg, Heidelberg (Germany)

3 More presentations in this session

Presentation thumbnail
Blunted atrial reverse remodeling a year after catheter ablation for atrial fibrillation and their long-term rhythm outcome
Doctor M. Kim (Yongin, KR)
Abstract Slides Video
Presentation thumbnail
Heart rate fragmentation as a marker of altered global autonomic nervous system activity : a novel predictor of atrial fibrillation occurrence in the general population
Doctor J. Guichard (Barcelona, ES)
Abstract Slides Video
Presentation thumbnail
Simultaneous metabolomics analysis of atrial tissue, pericardial fluid and blood reveal novel metabolite signatures of the pathophysiology and biomarkers related to permanent atrial fibrillation
Ms K. Harju (Kuopio, FI)
Abstract Slides Video

Access the full session

Session thumbnail
Insights in the pathophysiology of atrial fibrillation

The Event

Event poster

ESC Congress 2022

26 August - 29 August 2022
You may be interested in
thumbnail
Congress Presentation
What is atrial cardiomyopathy?
thumbnail
Congress Presentation
Novel computational approach enables tailoring catheter ablation to a patient and evaluating the role of reverse remodelling in atrial fibrillation recurrence
thumbnail
Congress Presentation
Mechanisms of atrial-fibrillation-induced ventricular dysfunction and recovery in the human left ventricular myocardium

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources